EPFL Life Sciences

When light boosts protein evolution actu.epfl.ch/news/when-ligh… #epfl

Three promotions in the Life Sciences actu.epfl.ch/news/three-pro… #epfl

EPFL joins $25 million research on cancer avoidance actu.epfl.ch/news/epfl-join… #epfl

Researchers at EPFL, Heidelberg University and Roche have built a human mini-bladder to show how urine composition weakens bladder tissue, helping infections recur even after antibiotics. go.epfl.ch/4b354f

New preclinical models for invasive lobular carcinoma have enabled the testing of a promising new drug that effectively slows tumor growth by targeting key features of the disease - opening the door to future clinical trials. go.epfl.ch/fd2a98

A two-layer safeguard for stem cell identity actu.epfl.ch/news/a-two-lay… #epfl

Pioneer factors steer chromatin remodeling for gene accessibility actu.epfl.ch/news/pioneer-f… #epfl

Electrical charges control gene expression actu.epfl.ch/news/electrica… #epfl

Can neurons be rejuvenated to restore memory? Our scientists show that switching on three “reprogramming” genes in a very small group of memory-related neurons restored memory in aged mice and in mouse models of Alzheimer’s disease. go.epfl.ch/71bfb4

🐻 Scientists from our university and Alaska Pacific University has developed an AI program that can recognize individual bears in the wild, despite the substantial changes that occur in their appearance over the summer season. go.epfl.ch/d8e2b4

Neural interfaces are the winners of the 2026 Queen Elisabeth Prize for Engineering. Nine scientists are honoured, including J.Bloch and G.Courtine (EPF/UNIL/CHUV,) recognized for their development of electronic spinal stimulation technology. actu.epfl.ch/news/neuroscie…

Juan Manuel García-Arcos joins EPFL as Ambizione Fellow actu.epfl.ch/news/juan-manu… #epfl

🧪 A new liver- and gut-targeted oral drug has shown, in a first clinical trial, its ability to reduce triglycerides and other blood lipids - major risk factors for cardiovascular disease, stroke, and pancreatitis. go.epfl.ch/502f54

Our scientists have identified a molecular pathway that protects cells from lipid oxidation and ferroptosis, a regulated form of cell death involved in aging and several diseases. go.epfl.ch/fa3d89

🧪 Our researchers have successfully engineered cells of the immune system to more effectively recognize cancer cells. The work, covered in two papers, turns the previously lab-based method into a full-blown immunotherapy strategy. go.epfl.ch/d969ad

How do cells help keep their protein levels steady even when their ability to make new proteins changes? A new study could shed light on how our bodies stay resilient when nutrients and other resources rise and fall. go.epfl.ch/29edf2

Crucial discovery from @EPFL & @JohnsHopkins: Enzyme KMT2D, a key epigenetic regulator in #ProstateCancer, offers a new therapeutic target. Potential for more effective treatments against resistant tumors. actu.epfl.ch/news/cracking-…

Our scientists have created a scalable 3D organoid model that captures key features of early limb development, revealing how a specialized signaling center shapes both cell identity and tissue organization. go.epfl.ch/e2d74e

The Swiss Laboratory Animal Science Association awarded on Wednesday its 2025 Prize to neuroscientist Mackenzie Mathis, Professor at EPFL, “for her outstanding contribution to the refinement of animal research.”  go.epfl.ch/6689f9

Congratulations to Carmen Sandi who has received the 2025 Mika Salpeter Lifetime Achievement Award! 🧠🏆 actu.epfl.ch/news/carmen-sa…